This Article Full Text Full Text (PDF) All Versions of this Article: 200208-864OCv1 167/6/862    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mairbäurl, H. Articles by Bärtsch, P. Search for Related Content PubMed PubMed Citation Articles by Mairbäurl, H. Articles by Bärtsch, P.

Nasal Epithelium Potential Difference at High Altitude (4,559 m)

Evidence for Secretion

Division of Sports Medicine, Department of Medicine, University of Heidelberg, Heidelberg, Germany; Medical and Research Services, Veterans Affairs Puget Sound Health Care System, University of Washington, Seattle, Washington; Intensive Care Unit, Department of Internal Medicine, University Hospital, Zürich, Switzerland; National Heart and Lung Institute, Imperial College School of Science, Technology and Medicine, London, United Kingdom

Correspondence and requests for reprints should be addressed to Heimo Mairbäurl, Division of Sports Medicine, Department of Medicine, University of Heidelberg, Luisenstraße 5, Geb. 4100, 69115 Heidelberg, Germany. E-mail: heimo_mairbaeurl{at}med.uni-heidelberg.de

Hypoxia inhibits activity and expression of ion transport proteins of cultured lung alveolar epithelial cells. Here we tested, whether in vivo hypoxia at high altitude (4,559 m) also inhibits lung ion transport. Transepithelial nasal potentials (NP) were determined as a surrogate measure of lung ion transport activity before and during the stay at altitude. In normoxia, total NP was approximately 20% higher in control subjects than in susceptibles to high-altitude pulmonary edema, but there was no difference between groups in amiloride-inhibitable NPs. At high altitude total NP increased 250% in both groups, whereas amiloride-sensitive NP decreased in control subjects only (-80%), and the chloride ion (Cl^-)–sensitive portion of NP almost doubled. Because many mountaineers suffer from nasal dryness at high altitude, a control study was performed in normobaric hypoxia (12% oxygen, 6 hours) at a controlled humidity of 50%. In this study, no change in total NP or its amiloride- and Cl-sensitive portions was observed. The increased Cl^- secretion at high altitude but no such change in normobaric hypoxia suggests that nasal dryness may stimulate local active Cl^- and fluid secretion in the upper respiratory tract. It is therefore uncertain whether similar changes also occur at the alveolar epithelium.

Key Words: hypoxia • nasal potential • sodium ion transport • chloride ion secretion • nasal dryness

This article has been cited by other articles:

				P. Bartsch and J. S. R. Gibbs Effect of Altitude on the Heart and the Lungs Circulation, November 6, 2007; 116(19): 2191 - 2202. [Full Text] [PDF]

				S. Guney, A. Schuler, A. Ott, S. Hoschele, S. Zugel, E. Baloglu, P. Bartsch, and H. Mairbaurl Dexamethasone prevents transport inhibition by hypoxia in rat lung and alveolar epithelial cells by stimulating activity and expression of Na+-K+-ATPase and epithelial Na+ channels Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1332 - L1338. [Abstract] [Full Text] [PDF]

				S. M. Rowe, F. Accurso, and J. P. Clancy Detection of Cystic Fibrosis Transmembrane Conductance Regulator Activity in Early-Phase Clinical Trials Proceedings of the ATS, August 1, 2007; 4(4): 387 - 398. [Abstract] [Full Text] [PDF]

				M. Maggiorini, H.-P. Brunner-La Rocca, S. Peth, M. Fischler, T. Bohm, A. Bernheim, S. Kiencke, K. E. Bloch, C. Dehnert, R. Naeije, et al. Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Ann Intern Med, October 3, 2006; 145(7): 497 - 506. [Abstract] [Full Text] [PDF]

				P. Bartsch, H. Mairbaurl, M. Maggiorini, and E. R. Swenson Physiological aspects of high-altitude pulmonary edema J Appl Physiol, March 1, 2005; 98(3): 1101 - 1110. [Abstract] [Full Text] [PDF]

				H. Mairbaurl, N. Mason, and P. Bartsch Nasal potentials at high altitude Eur. Respir. J., February 1, 2005; 25(2): 394 - 395. [Full Text] [PDF]

				C. Sartori, M. Egli, and U. Scherrer From the authors Eur. Respir. J., February 1, 2005; 25(2): 395 - 396. [Full Text] [PDF]

				C. Sartori, H. Duplain, M. Lepori, M. Egli, M. Maggiorini, P. Nicod, and U. Scherrer High altitude impairs nasal transepithelial sodium transport in HAPE-prone subjects Eur. Respir. J., June 1, 2004; 23(6): 916 - 920. [Abstract] [Full Text] [PDF]

				M. J. Tobin Asthma, Airway Biology, and Nasal Disorders in AJRCCM 2003 Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 265 - 276. [Full Text] [PDF]

				M. J. Tobin Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2003 Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 301 - 313. [Full Text] [PDF]

				H. Mairbaurl, F. Schwobel, S. Hoschele, M. Maggiorini, S. Gibbs, E. R. Swenson, and P. Bartsch Altered ion transporter expression in bronchial epithelium in mountaineers with high-altitude pulmonary edema J Appl Physiol, November 1, 2003; 95(5): 1843 - 1850. [Abstract] [Full Text] [PDF]

				H. L. Wallace, P. M. Barker, and K. W. Southern Nasal Airway Ion Transport and Lung Function in Young People with Cystic Fibrosis Am. J. Respir. Crit. Care Med., September 1, 2003; 168(5): 594 - 600. [Abstract] [Full Text] [PDF]